HEALTHSTAT NEWS
Opinion: STAT+: Enough, already: the problem with clinical trial data collection
The clinical research industry collects excessive data in trials, with nearly 30% of data not directly informing key decisions. Since 2005, procedures, endpoints, and data points collected have increased significantly, leading critics to argue that the 'more is better' approach undermines trial effectiveness.
Mentioned
Related Signal
Adjacent reporting
- STAT+: A key European clinical trial registry lacks complete and timely results, an analysis finds
- Watch live: Reimagining Clinical Trials – Expanding Access by Meeting Patients Where They Are
- Slow Alzheimer’s diagnoses ‘mean UK patients missing out on experimental treatments’
- STAT+: Pharmalittle: We’re reading about a Lilly obesity drug trial, statistics for an Alzheimer’s drug, and more